Regenix Biosciences Limited is a leading biosimilar company that has been revolutionizing the healthcare industry since its inception in 2018. The company was founded by Dr. Ramamurthy, a visionary and passionate leader with a deep understanding of biopharmaceuticals. Guided by his wisdom and foresight, Regenix Biosciences has grown rapidly, striving to fulfill its mission of delivering high-quality and affordable biologics to people worldwide.
At Regenix Biosciences, we realized that the increasing cost of biologic treatments was becoming a major hurdle for millions of people who required them. This prompted us to establish the company in 2018 and aimed to provide affordable, accessible, and innovative biopharmaceutical solutions to patients around the globe.
Over the years, Regenix Biosciences has made a mark in the biopharmaceutical industry with its unwavering commitment to developing cutting-edge biosimilars that meet the highest quality standards. The company's strong focus on research and development has led to the creation of a diverse pipeline of biosimilars aimed at treating various chronic and life-threatening diseases. Regenix Biosciences has managed to forge strategic partnerships with key stakeholders, including hospitals, research institutions, and regulatory agencies, to ensure that its products reach patients in need.
As Regenix Biosciences continues to grow, the company remains committed to its founding principles of quality, affordability, and innovation. With a promising pipeline of biosimilars in development and a strong foundation built on Dr. Ramamurthy's vision, Regenix Biosciences is poised to continue making a significant impact on global healthcare.